Avantor (AVTR) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.22
- Estimate
- $0.21
- Surprise
- +5.6%
- Revenue (period 2026-09-30)
- $1.70B
- Score today
- 5.2/10
Revenue source: xbrl.
How the report landed
Avantor (AVTR) beat the $0.21 estimate with adjusted EPS of $0.22 — a clear 5.6% upside surprise.
Coverage in the report window
- Stifel Maintains Hold on Avantor, Raises Price Target to $18 — benzinga, 2026-10-29
- Microsoft To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Thursday — benzinga, 2026-10-29
- Baird Maintains Outperform on Avantor, Raises Price Target to $18 — benzinga, 2026-10-29
Where TrendMatrix's rating stands now
TrendMatrix currently rates AVTR Sell at 5.2/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's +5.6% surprise compares with a +6.6% four-quarter average.
What argues against it
- Concentration risk — Supplier: sole-sourced raw materials
- Target reached (-16.8% upside)
- Quality below floor (3.4 < 4.0)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $16.69
- Stop
- $15.69
The stock trades at 33.4× trailing but 19.0× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: trading volume is running 2.8× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-10-29 — shown for context, not personalized investment advice.
AVTR at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $11.29B
- P/E (fwd)
- 19.0
- P/E (ttm)
- 33.4
- 52-week range
- $7.26–$17.45
- Off 52-week high
- 4.4%
- RSI (14)
- 69
- Volume vs avg
- 2.82×
- Score today
- 5.2/10